Plasma lipidomic signature of rectal adenocarcinoma reveals potential biomarkers
ARTIGO
Inglês
Agradecimentos: The authors wish to thank their colleagues of the Unidade Integrada de Farmacologia e Gastroenterologia (UNIFAG) and Laboratório de Análises Clínicas São José from Hospital Universitário São Francisco na Providência de Deus and FAPESP (2016/11905-2) for f
Rectal adenocarcinoma (RAC) is a common malignant tumor of the digestive tract and survival is highly dependent upon stage of disease at diagnosis. Lipidomic strategy can be used to identify potential biomarkers for establishing early diagnosis or therape
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP
2015/162191-4; 2016/11905-2
COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
Aberto
Plasma lipidomic signature of rectal adenocarcinoma reveals potential biomarkers
Plasma lipidomic signature of rectal adenocarcinoma reveals potential biomarkers
Fontes
|
Frontiers Research Foundation (Fonte avulsa) |